---
title: "CANCER RESEARCH TECHNOLOGY LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/92fca19a-93af-59d2-969e-e0dc8e0deb89
json: https://whiteintel.dev/api/public/dossier/92fca19a-93af-59d2-969e-e0dc8e0deb89
identifier: oo:GB-COH-01626049
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CANCER RESEARCH TECHNOLOGY LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-01626049`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/92fca19a-93af-59d2-969e-e0dc8e0deb89  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/92fca19a-93af-59d2-969e-e0dc8e0deb89  

## Cross-source identity

The same real-world entity, resolved across sources:

- **CANCER RESEARCH TECHNOLOGY LIMITED** — GLEIF · `lei:21380044FRQ2UIJN7A22` — https://whiteintel.dev/entity/d82384f3-f034-55d8-9c6f-97e339e3ae14

## Ownership & control

### Owners / controllers

- **CANCER RESEARCH UK** (beneficial owner) — 100% — https://whiteintel.dev/entity/fc9f6c91-c46c-5d66-85a2-9bf52001d021
- **CANCER RESEARCH UK** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/fc9f6c91-c46c-5d66-85a2-9bf52001d021
- **CANCER RESEARCH UK** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/fc9f6c91-c46c-5d66-85a2-9bf52001d021

### Holdings / subsidiaries

- **CANCER RESEARCH SCOTLAND INSTITUTE LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/faebe91f-6d57-568f-a44e-8b68d4c6a527
- **CANCER RESEARCH VENTURES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/9c19375b-4d09-5eeb-9cf1-a11c88befb7d
- **ACHILLES THERAPEUTICS UK LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/e02a1029-1cc3-5272-ad31-f50a19176c73
- **CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/f20cc3ae-3636-5036-b69a-8f5c035ebe75
- **CANCER RESEARCH SCOTLAND INSTITUTE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/faebe91f-6d57-568f-a44e-8b68d4c6a527
- **CANCER RESEARCH HORIZONS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/58b6dc8b-0df5-5618-aa08-151fcc8229a7
- **CANCER RESEARCH VENTURES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/9c19375b-4d09-5eeb-9cf1-a11c88befb7d
- **ACHILLES THERAPEUTICS UK LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/e02a1029-1cc3-5272-ad31-f50a19176c73
- **OLIGOTUNE LTD** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/29190ddf-6261-5e4b-bba4-31dff045f90b
- **CANCER RESEARCH UK SCOTLAND INSTITUTE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f20cc3ae-3636-5036-b69a-8f5c035ebe75

### UBO chain (walk to the ultimate owner)

A **5-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `01626049`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 1982-03-31
- **Registered office:** 2 Redman Place, London, E20 1JQ, England
- **SIC:** 72110

### Officers

- FAIRFIELD, Gillian Amanda — secretary · appointed 2021-09-28
- BISHOP, Hans Edgar — director · British · appointed 2026-03-09
- CHAMBRE, Peter Alan — director · British · appointed 2011-10-01
- FOULKES, Iain Walter, Dr — director · British · appointed 2013-01-23
- HICKSON, Anthony Charles — director · British · appointed 2018-08-07
- JENKINS, Anna Lisa Mary — director · British · appointed 2023-04-01
- LENGAUER, Christoph — director · Austrian · appointed 2023-04-01
- PRESTON, Heather Elizabeth, Dr — director · British,Canadian · appointed 2026-03-09
- THAKRAR, Hitesh — director · British · appointed 2025-01-01
- WOOSTER, Richard Francis — director · British,American · appointed 2026-03-09
- D'ARCY DOHERTY, Mary, Dr — secretary · British · resigned 1995-12-20
- HINCHLIFFE, Peter Michael — secretary · British · appointed 2002-10-01 · resigned 2002-11-04
- HIRD, Dean Michael, Doctor — secretary · British · appointed 1995-12-20 · resigned 1998-01-09
- PICKERING, Christopher David George — secretary · British · appointed 2000-07-26 · resigned 2001-01-15
- SCOTT, Diane Elizabeth — secretary · British · appointed 2002-11-04 · resigned 2003-04-01
- SCOTT, Diane Elizabeth — secretary · British · appointed 2002-06-11 · resigned 2002-10-01
- SEIDEL, David Gary — secretary · British · appointed 2001-01-15 · resigned 2002-06-11
- WALDRON, Andrew Jonathan — secretary · British · appointed 2003-04-01 · resigned 2021-09-28
- WALLACE, Roderick Iain — secretary · British · appointed 1998-01-09 · resigned 1998-07-29
- WILKINSON, John — secretary · British · appointed 1998-07-29 · resigned 2000-07-26

### Beneficial owners (Persons with Significant Control)

- [Cancer Research Uk](https://whiteintel.dev/entity/fc9f6c91-c46c-5d66-85a2-9bf52001d021) — 75–100% shares · corporate PSC · England — since 2022-08-01
- [Cancer Research Uk](https://whiteintel.dev/entity/fc9f6c91-c46c-5d66-85a2-9bf52001d021) — 75–100% shares · corporate PSC · England — ceased 2022-08-01

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/01626049
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/01626049

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **CANCER RESEARCH TECHNOLOGY LIMITED** — https://whiteintel.dev/entity/92fca19a-93af-59d2-969e-e0dc8e0deb89 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CANCER RESEARCH TECHNOLOGY LIMITED**. Human view: https://whiteintel.dev/entity/92fca19a-93af-59d2-969e-e0dc8e0deb89 · Structured JSON: https://whiteintel.dev/api/public/dossier/92fca19a-93af-59d2-969e-e0dc8e0deb89._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._